S'abonner

Connection

Depression And Alzheimer's Treatments At A Crossroads : Short Wave

Depression And Alzheimer's Treatments At A Crossroads : Short Wave

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem. As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

Frontiers Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

Music Therapy Today WFMT online journal Vol. 18, No. 1 by World Federation of Music Therapy - Issuu

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders

Geriatrics, Free Full-Text

Journal Club Neuroethics at the Core

PDF) Precision non-implantable neuromodulation therapies: a perspective for the depressed brain

Astrocyte and glutamate involvement in the pathogenesis of epilepsy in Alzheimer's disease - Dejakaisaya - 2021 - Epilepsia - Wiley Online Library

Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches

PDF) The Neural Crossroads of Psychiatric Illness: An Emerging Target for Brain Stimulation